IPO IMPATH PREDICTIVE ONCOLOGY
DEAD

Serial Number

76226598

Owner

Genzyme Corporation

Attorney

JOHN J BUTLER

First Use Date

Sep 30, 2000

Filing Date

Mar 19, 2001

Add to watchlist:

No watchlists yet
View on USPTO

IPO IMPATH PREDICTIVE ONCOLOGY Trademark

Serial Number: 76226598 • Registration: 2731185

IPO IMPATH PREDICTIVE ONCOLOGY is a trademark filed by Genzyme Corporation on March 19, 2001. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Genzyme Corporation (572 trademarks)

Cambridge, MA 02142

Entity Type: 03

Impath Inc. * (15 trademarks)

521 WEST 57TH STREET, 6TH FLOOR
New York, NY 10021

Entity Type: 03

Trademark Details

Filing Date

March 19, 2001

Registration Date

July 1, 2003

First Use Anywhere

September 30, 2000

First Use in Commerce

September 30, 2000

Published for Opposition

April 8, 2003

Cancellation Date

February 6, 2010

Goods & Services

Biopharmacogenomic services, namely research and development in targeted drug and diagnostic product discovery, drug development and diagnostic product and targeted therapies for others

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 6, 2010 C8..
CASE FILE IN TICRS
Mar 18, 2008 CFIT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 20, 2006 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 21, 2004 TCCA
REGISTERED-PRINCIPAL REGISTER
Jul 1, 2003 R.PR
PUBLISHED FOR OPPOSITION
Apr 8, 2003 PUBO
NOTICE OF PUBLICATION
Mar 19, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2002 CNSA
PREVIOUS ACTION COUNT WITHDRAWN
Jul 8, 2002 ZZZY
PAPER RECEIVED
May 9, 2002 MAIL
ASSIGNED TO EXAMINER
Mar 13, 2002 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2002 CRFA
NON-FINAL ACTION MAILED
Jun 15, 2001 CNRT
ASSIGNED TO EXAMINER
Jun 14, 2001 DOCK
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Apr 25, 2001 UNPR